Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mesalazine-induced multi-organ hypersensitivity.
Sposato B, Allegri MP, Riccardi MP, Chigiotti S, Nencioni C, Ricciardi B, Carli T, Cresti A, Perari MG, Migliorini MG, Toti M. Sposato B, et al. Among authors: carli t. Clin Drug Investig. 2010;30(6):413-7. doi: 10.1007/BF03256911. Clin Drug Investig. 2010. PMID: 20441247
Spontaneous abdominal bleeding associated with SARS-CoV-2 infection: causality or coincidence?
Sposato B, Croci L, Di Tomassi M, Puttini C, Olivieri C, Alessandri M, Ronchi MC, Donati E, Garcea A, Brazzi A, Migliorini MG, Chigiotti S, Nikiforakis N, Carli T, Canneti E, Strambio F, Cellini C, Nardangeli C, Allegri MP, Bianchi F, Bettini C, Perruzza M, Lanzarone N, Valentini L, Orselli P, Solari M, Cardaci S, Nofri M, Angeli G, Mangani F, Aloia E, Lanari A, Corridi M, Spargi G, Perrella A, Nencioni C. Sposato B, et al. Among authors: carli t. Acta Biomed. 2021 May 12;92(2):e2021199. doi: 10.23750/abm.v92i2.10142. Acta Biomed. 2021. PMID: 33988163 Free PMC article.
Pharmacokinetic and safety of raltegravir in pregnancy.
Croci L, Trezzi M, Allegri MP, Carli T, Chigiotti S, Riccardi MP, Ricciardi B, Toti M, Nencioni C. Croci L, et al. Among authors: carli t. Eur J Clin Pharmacol. 2012 Aug;68(8):1231-2. doi: 10.1007/s00228-012-1250-5. Epub 2012 Mar 1. Eur J Clin Pharmacol. 2012. PMID: 22382989 No abstract available.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients.
Saladini F, Meini G, Bianco C, Monno L, Punzi G, Pecorari M, Borghi V, Di Pietro M, Filice G, Gismondo MR, Micheli V, Penco G, Carli T, De Luca A, Zazzi M; ARCA Collaborative Group. Saladini F, et al. Among authors: carli t. Clin Microbiol Infect. 2012 Oct;18(10):E428-30. doi: 10.1111/j.1469-0691.2012.03917.x. Epub 2012 Jun 21. Clin Microbiol Infect. 2012. PMID: 22716970 Free article.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Darunavir-based dual therapy in HIV experienced patients.
Sterrantino G, Zaccarelli M, Di Biagio A, Rosi A, Bruzzone B, Cicconi P, Carli T, Biondi ML, Antinori A, Bartolozzi D, Penco G. Sterrantino G, et al. Among authors: carli t. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19782. doi: 10.7448/IAS.17.4.19782. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397526 Free PMC article.
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice.
Prosperi MC, Zazzi M, Punzi G, Monno L, Colao G, Corsi P, Di Giambenedetto S, Meini G, Ghisetti V, Bonora S, Pecorari M, Gismondo MR, Bagnarelli P, Carli T, De Luca A; ARCA Collaborative Group. Prosperi MC, et al. Among authors: carli t. J Med Virol. 2010 Dec;82(12):1996-2003. doi: 10.1002/jmv.21927. J Med Virol. 2010. PMID: 20981785
314 results